Cancer Care

Prostate Cancer Detection, Prevention & Treatment at EJGH

East Jefferson General Hospital has a tremendous track record in the treatment of prostate cancer. EJGH has been a leader in bringing the very latest techniques, technologies and talent to bear in the fight against prostate cancer. From Radiation to Hormone Treatment to Robotic Surgery, EJGH is an innovative, AND EFFECTIVE, fighter against prostate cancer.

Prostate cancer is one of the most common cancers in American men.

Genetics and age play a role in its development. But what other risks are involved? Below you will find information including frequently asked questions about prostate cancer along with information on screening and treatments for prostate cancer. If you, or someone you know, needs to consult with a physician regarding your prostate health, contact HealthFinder at 504-456-5000. They will be happy to connect you with a physician who meets your health and insurance needs.

  • 1 What is Prostate Cancer? Show More

    Prostate cancer is the most common cancer in American men, and in most men it grows very slowly. There are often no early prostate cancer symptoms. Prostate cancer treatment includes surgery, chemotherapy, cryotherapy, hormonal therapy, and/or radiation. In some instances, doctors recommend “watchful waiting.”

  • 2 What Causes Prostate Cancer? Show More

    Diet and genetics may be factors in prostate cancer development, but they are not the only ones. Research shows that our lifestyle choices factor in as well. Drinking, smoking and other choices can significantly heighten your risk factors. Age, race and family history, even a sedentary lifestyle can play a factor as well.

  • 3 How Can I Prevent Prostate Cancer? Show More

    It may not be possible to prevent prostate cancer, but you may be able to lower your risk. Taking Vitamin E, moving to a leaner diet high in fruits and vegetables, eliminating tobacco, minimizing your alcohol intake, exercising regularly and managing stress can all be beneficial in prevention/risk reduction.

  • 4 Is Prostate Cancer Screening Necessary? Show More

    Despite controversy, most doctors agree the prostate-specific antigen (PSA) blood test remains an important and necessary diagnostic tool. Men over 50 should absolutely add a prostate screening to their annual exam regimen. UroNav technology boasts 90% positive predictive values for prostate cancer detection in recent studies, available at East Jefferson Imaging Center.

  • Some screening tests are used because they have been shown to be helpful both in finding cancers early and decreasing the chance of dying from these cancers. Other tests are used because they have been shown to find cancer in some people; however, it has not been proven in clinical trials that use of these tests will decrease the risk of dying from cancer…

    Scientists study screening tests to find those with the fewest risks and most benefits. Cancer screening trials also are meant to show whether early detection (finding cancer before it causes symptoms) decreases a person’s chance of dying from the disease. For some types of cancer, finding and treating the disease at an early stage may result in a better chance of recovery.

    There is no standard or routine screening test for prostate cancer.

    Screening tests for prostate cancer are under study, and there are screening clinical trials taking place in many parts of the country. Information about ongoing clinical trials is available from the National Cancer Institute at www.cancer.gov

    • Digital rectal exam (DRE)is an exam of the rectum. The doctor or nurse inserts a lubricated, gloved finger into the lower part of the rectum to feel the prostate for lumps or anything else that seems unusual.
    • Prostate-specific antigen test (PSA)is a test that measures the level of PSA in the blood. PSA is a substance made mostly by the prostate that may be found in an increased amount in the blood of men who have prostate cancer. The level of PSA may also be high in men who have an infection or inflammation of the prostate or benign prostatic hyperplasia (BPH; an enlarged, but noncancerous, prostate). If a man has a high PSA level and a biopsy of the prostate does not show cancer, a prostate cancer gene 3 (PCA3) test may be done. This test measures the amount of PCA3 in the urine. If the PCA3 level is high, another biopsy may help diagnose prostate cancer.

Technologies for the Detection and Treatment of Prostate Cancer

UroNav: a Breakthrough in Prostate Cancer Detection

EJGH is proud to offer this powerful solution for targeted biopsy of the prostate. The UroNav fusion biopsy system offers a cutting edge option for many patients with elevated and/or rising PSA levels. UroNav fuses pre-biopsy MR images of the prostate with ultrasound-guided biopsy images in real time, for excellent delineation of the prostate and suspicious lesions.

Targeted MR/ultrasound biopsy is poised to become the new standard in prostate care, and EJGH is pleased to offer this powerful solution to our patients.

 

EJGH: A Leader in Robotic Surgery

With the addition of the S-Generation da Vinci Robotic Surgical System, East Jefferson General Hospital stands at the fore in the areas of robotic and minimally invasive surgery. Traditional prostate surgery calls for an incision running from the navel to the groin. The surgery is usually followed by several days of hospitalization and a recovery period that can take weeks.

Today, da Vinci represents the gold standard in prostatectomy. Robotic Prostatectomy allows for three incisions that are each less than an inch long. Patients are usually hospitalized a couple of days and overall recovery times are reduced by several days.